Conference Introduction

To thoroughly implement the national strategic initiatives for actively addressing population aging and the spirit of the Healthy China 2030 Planning Outline (a national blueprint for healthcare development in China), we vigorously advance the national innovation - driven strategy, deeply enforce the national mass entrepreneurship and innovation initiatives, and focus on facilitating the translation and commercialization of medical scientific and technological achievements. We aim to build a bridge for mutual communication and collaboration among medicine, healthcare, research, education, and enterprises.

This conference, themed “Innovation and Translation”, will feature multiple sub - forums. It is designed to provide a multi - disciplinary platform for clinical physicians, medical scientific researchers, and innovative pharmaceutical enterprises. Here, professionals can engage in collaborative diagnosis and treatment, clinical innovation practices, translational medicine research, medical artificial intelligence applications, integration of big data with advanced technologies, and the translation of innovative technologies. Thereby, we strive to promote the integrated development of clinical practice, basic research, and the advancement of new technologies in relevant fields.

By deepening translational medicine research, integrating multi - disciplinary resources, and addressing the diverse needs of the elderly population (a society where people of all ages can thrive), this conference will contribute a core driving force to building an age - inclusive society for all and realizing the goals of Healthy China 2030, aligning with the long - term development blueprint of the medical and health industry.